insights_auto
Why is CUV up 2,29%?
Dive Deeperchevron_right
CUV:ASX
Clinuvel Pharmaceuticals Ltd
A$7,59
arrow_upward
+2,29%(+0,17) 1D
16 Nov., 16:10:15 GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CUV...
Open
A$7,43
High
A$7,65
Low
A$7,38
Mkt. cap
383,20 m
Avg. vol.
157,65 k
Volume
90,51 k
Dividend
0,66%
Quarterly dividend
A$0,01
Ex-dividend date
03 Sep. 2026
P/E ratio
11,36
52-wk high
A$13,48
52-wk low
A$6,62
EPS
A$0,67
Shares outstanding
50,49 m
No. of employees
16
Open
A$7,43
High
A$7,65
Low
A$7,38
Mkt. cap
383,20 m
Avg. vol.
157,65 k
Volume
90,51 k
Dividend
0,66%
Quarterly dividend
A$0,01
Ex-dividend date
03 Sep. 2026
P/E ratio
11,36
52-wk high
A$13,48
52-wk low
A$6,62
EPS
A$0,67
Shares outstanding
50,49 m
No. of employees
16
News stories
From web sources and news partners
marketscreener.com
·
44 minute gelede
Nasdaq, S&P 500 Fall For Third Day as Nvidia Sell-Off Continues
TV News Check
·
56 minute gelede
Dow Drops 739, Nasdaq Falls 627, S&P 500 Sheds 145
Investing.com
·
59 minute gelede
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.41%
ChartMill
·
2 uur gelede
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
About Clinuvel Pharmaceuticals Ltd
CEOPhilippe J. Wolgen
Employees16
Founded1987
Headquarters-
SectorHealth Care
Industry-
Websiteclinuvel.com